glp 1 in 2025 keep this crucial hormone in mind If you're your 40s or 50s and considering a GLP-1, therapy may need to be part of the conversation too. These medications work different ways, and for some women Glp1s mess with your hormones?

Proposed Mechanism BPC-157 appears to work through multiple pathways: Maintaining vesicular integrity (affecting VMATs and dopamine transporters) Possibly occupying its own vesicular storage sites Competing for dopamine receptor binding Functionally substituting when dopaminergic neurons are lost This last property, essentially filling in for missing dopamine function, would explain why the peptide counteracts both receptor agonists (apomorphine) and antagonists (haloperidol, fluphenazine, clozapine, sulpiride) with equal effectiveness

The peptide has been the subject of multiple in vitro and animal studies (and a smaller number of human observational studies) published in Bulletin of Experimental Biology and Medicine , Biogerontology , and other journals

Conversely, a panel of genes that promote fatty acid oxidation was induced 2~3 fold in these same mice

Mitochondrial quality control mechanisms as potential therapeutic targets in sepsis-induced multiple organ failure